Kiniksa Pharmaceuticals, Ltd.

KNSANASDAQHealthcare● Active

$48.52

+$0.10(+0.20%)

Market Cap$3.6B

P/E Ratio—

52W High$59.87

52W Low$26.27

Avg Volume693K

Open$48.80

Beta0.12

Overview

Kiniksa Pharmaceuticals, Ltd. (KNSA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KNSA · as of Feb 24, 2026

Latest filing snapshot

366

+51+16.19%vs prior year

Kiniksa Pharmaceuticals, Ltd. (KNSA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

366

Change (1Y)

+51

Growth % (1Y)

+16.19%

Revenue / Employee

$1.85M

Net Income / Employee

$161.2K

Market Cap

$3.6B

KNSA Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-24	2025-12-31	366	+51	+16.19%
2025-02-25	2024-12-31	315	+18	+6.06%
2024-02-28	2023-12-31	297	+77	+35.00%
2023-03-02	2022-12-31	220	+5	+2.33%
2022-02-24	2021-12-31	215	+47	+27.98%
2021-02-25	2020-12-31	168	+31	+22.63%
2020-03-05	2019-12-31	137	+26	+23.42%
2019-03-12	2018-12-31	111	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

APLS

Apellis Pharmaceuticals, Inc.

705$5.3B #2

ADPT

Adaptive Biotechnologies Corporation

619$2.7B #3

FOLD

Amicus Therapeutics, Inc.

499$4.5B #4

KNSA

Kiniksa Pharmaceuticals, Ltd.YOU

366$3.6B #5

CPRX

Catalyst Pharmaceuticals, Inc.

181$3.8B #6

IDYA

IDEAYA Biosciences, Inc.

131$2.7B #7

CDTX

Cidara Therapeutics, Inc.

38$5.6B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KNSA peer comparison

About KNSA employees

KNSA Employees · Headcount

Kiniksa Pharmaceuticals, Ltd. (KNSA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Kiniksa Pharmaceuticals, Ltd. had 366 full-time employees globally. Full-time employees only. Global consolidated headcount.

Kiniksa Pharmaceuticals, Ltd. employs 366 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.85M, reflecting the company's operational efficiency.

Kiniksa Pharmaceuticals, Ltd.'s workforce increased by 51 (16.19%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Kiniksa Pharmaceuticals, Ltd.'s revenue per employee of $1.85M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

KNSA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Kiniksa Pharmaceuticals, Ltd. had 366 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Kiniksa Pharmaceuticals, Ltd. employee counthow many employees does Kiniksa Pharmaceuticals, Ltd. haveKNSA total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-24